About Werner Doyle, M.D.
Form D filings for NeuroView Technology in 2023 list Werner Doyle, M.D. as director.
Werner Doyle, M.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Werner Doyle, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Werner Doyle, M.D. works with at each company, as listed on that company's latest Form D.
NeuroView Technology, Inc. · Form D, Dec 20, 2023
JK
James Karwel
Chief Executive Officer and director
LR
Louis Rauchenberger
Director
RD
Ruben Kuzniecky, M.D.
Executive officer and director
SD
Steve Pacia, M.D.
Director